From reddit: Go to Livimmune r/Livimmune •
Post# of 147640
(Total Views: 394)
Posted On: 10/29/2024 8:03:46 AM
From reddit:
Go to Livimmune
r/Livimmune
•
5 hr. ago
BuildGoodThings
Keeping up in 2024 with the research.
Cytodyn is getting busy and they are backing up each of these indications with presentations, papers, studies, and trials since March 2024 for a reason IMO. They are gathering and presenting all this data to show the depth of what the molecule can do so that large pharma realizes that they will need to make serious offers to this company which is now run by a team of knowledgeable and effective people. Here below are just some of the things happening. This list doesn't include everything.
Cancer Program
Cancer: CRC (colorectal)
awaiting phase 2 trial protocol approval and screening
(n.b. previous unpublished preclinical study)
Cancer: Glioblastoma (brain)
awaiting pre-clinical study results
Cancer: TNBC (breast)
awaiting 2 clinical trials papers
awaiting start of additional preclinical study
(n.b. 3 previous clinical trials completed)
HIV Program
Lines of research include
leronlimab as monotherapy
ART + leronlimab
PeP combo with ART + bNAbs (PGT121-LS & VRC07-523-LS) + Leronlimab (also potential cure)
Cure- Gene therapy, AAV viral vector
Cure- Stem cell (includes announced LATCH trial)
PrEP Mothers to newborns (leronlimab PLS)
4 preclinical presentations (oral and poster) made in 2024
1 preclinical paper published in 2024
awaiting a clinical trial paper
awaiting start of 2 clinical trials (LATCH)
(n.b. numerous previous clinical trials completed)
Inflammation Program
Alzheimer's
awaiting start of clinical trial
Chronic Fatigue Syndrome
awaiting start of clinical trial
Covid-19: Mild-Moderate
published phase 2 paper in 2024
awaiting start of clinical trial
(n.b. previous clinical trial completed)
Covid-19: Severe & Critical
awaiting clinical trial paper
(n.b. previous clinical trial completed)
Covid-19: PASC (longhaulers)
published phase 2 letter to editor in 2024
(n.b. previous clinical trial completed)
Inflammation (Chronic in HIV patients)
awaiting phase 2 trial patient screening to begin
MASH (liver)
preclinical study results released by press release in 2024
awaiting additional preclinical study
awaiting a clinical trial paper
(n.b. previous clinical trial completed)
Long Acting Leronlimab Program
Long-acting Leronlimab (in HIV)
1 preclinical presentation made in 2024
Go to Livimmune
r/Livimmune
•
5 hr. ago
BuildGoodThings
Keeping up in 2024 with the research.
Cytodyn is getting busy and they are backing up each of these indications with presentations, papers, studies, and trials since March 2024 for a reason IMO. They are gathering and presenting all this data to show the depth of what the molecule can do so that large pharma realizes that they will need to make serious offers to this company which is now run by a team of knowledgeable and effective people. Here below are just some of the things happening. This list doesn't include everything.
Cancer Program
Cancer: CRC (colorectal)
awaiting phase 2 trial protocol approval and screening
(n.b. previous unpublished preclinical study)
Cancer: Glioblastoma (brain)
awaiting pre-clinical study results
Cancer: TNBC (breast)
awaiting 2 clinical trials papers
awaiting start of additional preclinical study
(n.b. 3 previous clinical trials completed)
HIV Program
Lines of research include
leronlimab as monotherapy
ART + leronlimab
PeP combo with ART + bNAbs (PGT121-LS & VRC07-523-LS) + Leronlimab (also potential cure)
Cure- Gene therapy, AAV viral vector
Cure- Stem cell (includes announced LATCH trial)
PrEP Mothers to newborns (leronlimab PLS)
4 preclinical presentations (oral and poster) made in 2024
1 preclinical paper published in 2024
awaiting a clinical trial paper
awaiting start of 2 clinical trials (LATCH)
(n.b. numerous previous clinical trials completed)
Inflammation Program
Alzheimer's
awaiting start of clinical trial
Chronic Fatigue Syndrome
awaiting start of clinical trial
Covid-19: Mild-Moderate
published phase 2 paper in 2024
awaiting start of clinical trial
(n.b. previous clinical trial completed)
Covid-19: Severe & Critical
awaiting clinical trial paper
(n.b. previous clinical trial completed)
Covid-19: PASC (longhaulers)
published phase 2 letter to editor in 2024
(n.b. previous clinical trial completed)
Inflammation (Chronic in HIV patients)
awaiting phase 2 trial patient screening to begin
MASH (liver)
preclinical study results released by press release in 2024
awaiting additional preclinical study
awaiting a clinical trial paper
(n.b. previous clinical trial completed)
Long Acting Leronlimab Program
Long-acting Leronlimab (in HIV)
1 preclinical presentation made in 2024
(11)
(0)